Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Respected Research: PTJ's Influence Continues To Rise

Jul 1, 2020/News

The latest impact factor reports once again put APTA's journal in the top 10 most-cited rehab research publications.

BMJ: Guideline Strongly Recommends Against Arthroscopy for 'Nearly All' Patients With Knee OA or Meniscal Tears

May 12, 2017/News

A new guideline makes a strong recommendation against the use of arthroscopy in nearly all patients with degenerative knee disease. Instead, authors recommend conservative treatment for nearly all patients.

Researchers: Studies Show Telehealth to Be 'Feasible and Effective' in Rehab

Sep 19, 2022/Review

A systematic review involving more than 200,000 patients with a variety of conditions revealed consistently positive results for telerehab.

Viewpoints

Mar 1, 2021/Column

View letters to the editor, online comments from readers, and responses to timely questions that APTA poses for member response.

Meet Promising and Proven Leaders in the Physical Therapy Profession

Nov 1, 2024/Feature

Bringing the physical therapy profession into the future requires strong leadership.

Membership Eligibility and Application Forms

There are multiple paths to join the APTA community.

TRICARE: The US Military's Health Care Program

Dec 1, 2016/Column

A look at 2 issues: Are PTAs reimbursable? Also, regions will consolidate.

Three-Dimensional Instrumented Gait Analysis for Children With Cerebral Palsy: An Evidence-Based Clinical Practice Guideline (CPG+)

Apr 1, 2024/CPG

Best practice statements provide guidance for clinicians about the preferred characteristics of 3-dimensional instrumented gait analysis laboratories, including instrumentation, staffing, and reporting practices.

Viewpoints: April 2024

Apr 1, 2024/Column

Video on Mentoring Has PTs Talking

Coronavirus Update: July 7

Jul 7, 2021/Article

APTA COVID-19 Outcome Measures, "profound brain changes," updated return-to-sport guidance, and more.